HOME >> MEDICINE >> NEWS
Drug-eluting stent controversy explored in the American Heart Hospital Journal

Shelton, Conn. - August 08, 2007 The Summer 2007 issue of The American Heart Hospital Journal explores one of the pivotal issues in cardiology today, the drug-eluting stent (DES). Through commentaries from ten leading national and international specialists, the issue presents a comprehensive discussion on the explosive growth and the potential risks of DESs.

The issue reports on the initial enthusiasm for drug-eluting stents, the great advances made possible by their use, and explores the significance of the benefits and disadvantages revealed through their high-volume adoption.

Dr. Ulrich Sigwart of University Hospital in Geneva, Switzerland, author of one of the studies, examines the sobering current appraisal of DES use, in contrast to the triumphs of their early success. Subacute stent thrombosis due to incomplete intimal coverage, the formation of blood clots that can occur when the inner layers of blood vessels are not fully treated, remains the Achilles heel of DES use, says Dr. Sigwart. The polymer matrix used for the delivery of drugs, which clearly induces inflammatory responses, may, in part, be responsible for very late thrombosis.

Dr. Renu Virmani and colleagues at the CVPath Institute of Gaithersburg, Maryland base the judgments in their article on the evidence obtained through pathologic studies of patients dying after stent implantation. These data indicate that DESs cause both substantial impairment in arterial healing characterized by lack of complete re-endothlialization (the re-healing of the inner surfaces of vessels after stenting) and persistence of fibrin, a protein that indicates blood clotting, when compared with bare metal stents. This delayed healing is the primary substrate underlying all cases of late DES thrombosis at autopsy.

In contrast, Drs. Williams and Abbott, of Brown Medical School and affiliated with Rhode Island Hospital, note, DESs are a revolutionary advancement in interventional
'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
8-Aug-2007


Page: 1 2

Related medicine news :

1. Drug-eluting and absorbable stents push interventional frontiers
2. Drug-eluting stents outperform radiation treatment for coronary restenosis in bare metal stents
3. Drug-eluting stents may cause allergic reactions
4. Drug-eluting stents successfully treat vein-graft disease
5. SCAI news: Drug-eluting stents prove mettle in heart attack patients
6. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
7. New study counts the economic cost of persistent pain in Australia
8. New biodegradable magnesium stents for coronary arteries
9. Emory University researchers find persistent and severe asthma associated with obesity
10. Persistent smokers may have higher risk to become depressed than never smokers
11. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/16/2019)... ... February 15, 2019 , ... ... surgical centers (ASCs) throughout the U.S., celebrates the formation of its 200th ASC ... to open later this year. , “We continue to see the demand increase ...
(Date:2/13/2019)... , ... February 14, 2019 , ... At this year’s ... entrepreneurs leapt to their feet and cheered as it was announced that the company ... course of the last few years, the company has optimized its revolutionary “Shopping Annuity” ...
(Date:2/13/2019)... ... 13, 2019 , ... With Valentine’s Day tomorrow and love in the air, ... sharing 7 tips to ensure ‘Safe Sex’: , 1. Talk To Your Partner. ... safe sex. Having clear, open, and honest communication is key so that both partners ...
(Date:2/13/2019)... ... ... issue for 1 in 6 couples; in about 50% of these cases the infertility is ... sperm count over the last 40 years was featured in articles in the NY ... in the midst of a severe, perhaps irreversible, male infertility crisis. , A promising ...
(Date:2/13/2019)... Ill. (PRWEB) , ... February 13, 2019 , ... Surgery ... significantly effective and safe treatment for obstructive sleep apnea (OSA), resulting in benefits that ... cardiovascular risk, according to a new study. , MMA should be regarded as the ...
Breaking Medicine News(10 mins):
(Date:2/16/2019)... Belgium (PRWEB) , ... February 15, 2019 , ... ... and observations from multiple studies and patient registries demonstrating the value of SelectMDx ... of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), taking place in San Francisco, ...
(Date:2/14/2019)... ... February 14, 2019 , ... ... focuses on developing and commercializing minimally-invasive, innovative spinal technologies, today announced a ... Surgical name better emphasizes our commitment to delivering new, cutting-edge, surgical solutions ...
(Date:2/13/2019)... Ky. (PRWEB) , ... February 13, 2019 , ... ... thousandth patient! The clinic opened their doors in November of 2013 and, to ... ejaculation, low testosterone, and Peyronies Disease. With an over 90% success rate, The ...
Breaking Medicine Technology:
Cached News: